ROSEN Law Firm Encourages Aquestive Therapeutics Investors to Seek Legal Counsel

The national trial lawyers firm is advising investors to take action following recent developments.

Apr. 8, 2026 at 12:27am

A photorealistic studio still-life featuring a stack of legal documents, a gavel, and a magnifying glass, conceptually representing the legal process of investigating corporate issues and protecting investor rights.A law firm's investigation into a pharmaceutical company's recent events aims to protect the interests of affected investors.NYC Today

The ROSEN Law Firm, a global investor rights law practice, is encouraging investors in Aquestive Therapeutics, Inc. to seek legal counsel following recent events that may impact the company's stock performance. The firm is investigating potential securities claims on behalf of Aquestive Therapeutics investors and advising them to take appropriate action to protect their interests.

Why it matters

Aquestive Therapeutics is a pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems. Any legal or regulatory issues surrounding the company could significantly impact investor confidence and the stock price, making it important for affected shareholders to understand their options.

The details

The ROSEN Law Firm is investigating potential securities claims on behalf of shareholders of Aquestive Therapeutics resulting from allegations or developments that may have negatively impacted the company. The firm is advising investors to contact them to discuss the situation and their legal rights.

  • The ROSEN Law Firm announcement was made on April 7, 2026.

The players

ROSEN Law Firm

A global investor rights law practice that specializes in representing investors in securities fraud cases.

Aquestive Therapeutics, Inc.

A pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems.

Got photos? Submit your photos here. ›

What they’re saying

“We encourage Aquestive Therapeutics investors to contact us to discuss their legal rights and options.”

— Laurence Rosen, Managing Partner, ROSEN Law Firm

What’s next

The ROSEN Law Firm is advising Aquestive Therapeutics investors to contact them to discuss potential legal action and their rights as shareholders.

The takeaway

This announcement highlights the importance for investors to stay informed and take appropriate action to protect their interests when issues arise with the companies they have invested in.